Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Raises Target Price to $14
Terns Pharmaceuticals Currently Down Seven Consecutive Days, on Track for Record Losing Streak -- Data Talk
Viking, Structure, Terns Benefitting From Disappointing Novo Nordisk Weight Loss Data
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
Terns Pharmaceuticals Director Buys $5 Million in Company Stock